SMC
Sovaldi hurdles first drug pricing barrier
June 10, 2014Sales and Marketing Gilead, SMC, Scotland, hep C, sofosbuvir, sovaldi
Scotland’s NHS will pay for Gilead’s new hepatitis C pill Sovaldi despite rising concern over its high cost. The Scottish …
Scotland reforms will see drug access improve
February 3, 2014Sales and Marketing PACE, SMC, Scotland, drugs, neil
Scotland is set to overhaul its medicines access system after complaints from charities and interest groups that patients have been …
SMC approves Inlyta
November 13, 2013Sales and Marketing Pfizer, SMC, Sutent, inylta, rcc
Pfizer’s kidney cancer drug Inlyta has been approved by the drugs watchdog in Scotland, making it the only country in …
SMC must be ‘more flexible’ – health minister
October 9, 2013Sales and Marketing CDF, NICE, SMC
The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …
Scotland fund for rare diseases
January 17, 2013Sales and Marketing SMC, Scotland, rare diseases
The Scottish government is launching a £21 million fund in March to meet the costs of patients who require orphan …
SMC first to give Fycompa thumbs-up
December 12, 2012Sales and Marketing Eisai, Fycompa, SMC, Scotland, epilepsy
The Scottish Medicines Consortium (SMC) has approved Eisai’s first-in-class epilepsy drug Fycompa for use in the NHS in Scotland – …
SMC put under review
November 20, 2012Sales and Marketing Alex Neil, NICE, SMC, Scotland
The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …
Scottish watchdog rejects Yervoy
May 14, 2012Sales and Marketing BMS, Cancer, NICE, SMC, Yervoy, melanoma
The Scottish Medicines Consortium is not recommending Bristol-Myers Squibb’s melanoma treatment Yervoy. The SMC said that Yervoy (ipilimumab), which has …
Head-to-head: Nice and the SMC
August 16, 2006Research and Development, Sales and Marketing NICE, SMC, healthcare
The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the Herceptin …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
EnteroBiotix appoints former GSK Chief Medical Officer to board
